STAT3 and osteosarcoma: LRP8 has been implicated in various malignancies, with studies showing that its overexpression increases phospho-STAT3 (p-STAT3) levels, a marker associated with metastasis and poorer outcomes in osteosarcoma (Zheng et al, 2021).